REVISED AND RESTATED FINANCIAL STATEMENTS (Tables)

12 Months Ended

Dec. 31, 2024

Accounting Changes and Error Corrections [Abstract]

Restatement of financial statements

	Impact of correction of error
Twelve months ended December 31, 2024	As previousy reported			Adjustments			As restated
Net cash used in operating activities of continuing operations	$	(5,858,147	)	$	3,092,350		$	(2,765,797	)
Net cash provided by financing activities of continuing operations	$	6,068,077		$	(3,092,350	)	$	2,975,727

During the preparation of the financial statements for the three months ended March 31, 2024, the Company identified and revised its classification for all its outstanding common stock amount per par value of $0.001 with additional paid-in-capital related with a 1-for-75,000 reverse split executed on January 9, 2024. The impact of this adjustment decreased $1,804,774 to common stock and offsetting increase to additional paid-in-capital as of December 31, 2023. Additionally, the Company identified and revised its series B and series C preferred stock values which increased its preferred stock by $20,004 and decreased additional paid-in-capital by the same amount as of December 31, 2023.

The following tables summarize the impact of the corrections on the Company’s condensed consolidated balance sheet as of December 31, 2023:

Consolidated balance sheet

Schedule of consolidated balance sheet

	Impact of revision
December 31, 2023	As previously reported			Adjustments			As restated
Preferred stock	$	76,976,716		$	20,004		$	76,996,720
Common stock		1,804,799			(1,804,774	)		25
Additional paid-in-capital		(9,365,982	)		1,784,770			(7,581,212	)
Total stockholders' equity	$	731,418		$	–		$	731,418